GLIOFLUX LIMITED

Date	Description
05/11/255 November 2025 New	Appointment of Mrs Nasreen Tabassum as a director on 2025-11-05 View Document
05/11/255 November 2025 New	Notification of Nasreen Tabassum as a person with significant control on 2025-11-05 View Document
05/11/255 November 2025 New	Cessation of Muhammad Tahir Javaid as a person with significant control on 2025-11-05 View Document
12/09/2512 September 2025 New	Micro company accounts made up to 2024-12-31 View Document
10/05/2510 May 2025	Director's details changed for Muhammad Tahir Javaid on 2025-05-07 View Document
09/04/259 April 2025	Confirmation statement made on 2025-04-09 with no updates View Document
17/03/2517 March 2025	Confirmation statement made on 2025-03-17 with updates View Document
06/03/256 March 2025	Notification of Muhammad Tahir Javaid as a person with significant control on 2025-03-06 View Document
06/03/256 March 2025	Cessation of Nasreen Tabassum as a person with significant control on 2025-03-06 View Document

06/03/256 March 2025	Termination of appointment of Nasreen Tabasum as a director on 2025-03-06 View Document
31/12/2431 December 2024	Annual accounts for year ending 31 Dec 2024 View Accounts
18/12/2418 December 2024	Confirmation statement made on 2024-12-10 with updates View Document
16/12/2416 December 2024	Cessation of Muhammad Tahir Javaid as a person with significant control on 2024-09-03 View Document
16/12/2416 December 2024	Notification of Nasreen Tabassum as a person with significant control on 2024-09-03 View Document
16/12/2416 December 2024	Appointment of Mrs Nasreen Tabasum as a director on 2024-09-03 View Document
13/12/2413 December 2024	Statement of capital following an allotment of shares on 2024-09-01 View Document
13/12/2413 December 2024	Registered office address changed from Unit 57 D65 the Winning Box 27-37 Station Road Hillingdon London Hayes UB3 4DX United Kingdom to 11 Flora Road Birmingham B25 8BH on 2024-12-13 View Document
11/12/2311 December 2023	Incorporation View Document